転移性癌の予防、治療、または管理のための併用療法に用いるためのＡＸＬ阻害薬

Title:

転移性癌の予防、治療、または管理のための併用療法に用いるためのＡＸＬ阻害薬

Document Type and Number:

Japanese Patent JP5858789

Kind Code:

B2

Abstract:

This invention is directed to methods of preventing, treating or managing cancer, preferably metastatic cancer, in a patient. The methods comprise administering an effective amount of an Axl inhibitor in combination with the administration of an effective amount of one or more chemotherapeutic agents.

More Like This:

JP2005536516	Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizer / dispersant
JP5154609	Methods for Assaying the Effect of Test Substances on PTH Production
JP2008509187	Trifluoromethyl-substituted benzamide as a kinase inhibitor

Inventors:

Etc.
Sasha, Holland
Payang, Donald G.

Application Number:

JP2011546409A

Publication Date:

February 10, 2016

Filing Date:

January 15, 2010

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Rigel Pharmaceuticals, Inc.

International Classes:

A61K31/502; A61K31/282; A61K31/337; A61K31/517; A61K31/7034; A61K31/7068; A61K33/243; A61P35/00

Foreign References:

WO2008083367A2

Other References:

Cancer Lett,2008,Vol.268,No.2,pp.314-324.

Attorney, Agent or Firm:

Yoshiyuki Kawaguchi
Shinichi Sanuki
Takeshi Niwa

Previous Patent: ブレオマオシン水解酵素の活性を指標としたアトピー性皮膚炎による乾燥�...

Next Patent: JPS5858790